Antisense oligonucleotide inhibitors for the treatment of cancer: 2. Toxicological properties of phosphorothioate oligodeoxynucleotides.
Henry
S P
SP
Department of Toxicology, Isis Pharmaceuticals, Inc., Carlsbad, CA 92008, USA. shenry@isisph.com
Monteith
D
D
Levin
A A
AA
D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D016376:Oligonucleotides, Antisense / Q000633:toxicity*; D013873:Thionucleotides / Q000633:toxicity*
D000970:Antineoplastic Agents; D016376:Oligonucleotides, Antisense; D013873:Thionucleotides